Next-Generation Antibody Discovery and Development Technology


Year of Award:
2016
Award Type:
R44
Project Number:
2R44CA187852-02A1
RFA Number:
PAR-13-327
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
JOHNSON, DAVID SCOTT
Other PI or Project Leader:
N/A
Institution:
GIGAGEN, INC.
Next-Generation Antibody Discovery and Development TechnologyOrganization: GigaGen Inc.PI: David S. Johnson, Ph.D.Despite an enormous investment in novel therapies, cancer still accounts for 25% of US deaths, killing >1500people every day. For example, on